Subject to change.
Subject to change.
Richard Levenson, MD, FCAP, is professor and vice chair for strategic technologies, Department of Pathology and Laboratory Medicine, UC Davis Health. He received his MD at University of Michigan and pathology training at Washington University, followed by a cancer research fellowship at Univ. of Rochester and faculty positions at Duke and Carnegie Mellon. He joined Cambridge Research & Instrumentation, becoming VP of Research before assuming his present position at UC Davis. He helped develop multispectral microscopy and small-animal imaging systems, birefringence microscopy, multiplexed ion-beam imaging (MIBI), and slide-free as well as enhanced-content microscopy approaches, and is an inventor on some 15 patents. He is section editor for Archives of Pathology and is on the editorial board of Lab. Invest. and AJP. Regrettably, he also taught pigeons histopathology and radiology. He is a recipient of the 2018 UC Davis Chancellor's Innovator of the Year award and is a Fellow of SPIE.
Digital pathology offers more than technological progress—it creates opportunities to bring patients closer to their diagnoses and strengthen the role of pathology in patient care. This session marks the first public program of the Digital Pathology Association’s Patient Engagement Committee, formed to advance best practices for involving patients and the public in digital pathology.
Speakers will share perspectives from a patient, leaders in patient and public involvement, and pathologists committed to patient-centered digital pathology practice. Together, they will demonstrate how direct visualization of pathology digital images, co-created educational resources, and clear communication of diagnostic information enhanced via the digital slide can empower patients to better understand their conditions and participate in care decisions. The discussion will also highlight how these approaches provide unique opportunities for health systems to differentiate themselves, foster trust and improve patient and family support, as well as highlighting hidden benefits on the investment in digital pathology.